Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Children's Oncology Group
National Institutes of Health Clinical Center (CC)
Perspective Therapeutics
National Institutes of Health Clinical Center (CC)
Fundación de investigación HM
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Universidad Nacional Autonoma de Mexico
Peking Union Medical College Hospital